Description

There is an urgent need for more effective therapies for individuals who have been hospitalized with COVID-19. Thousands of independent trials have been launched over the past year evaluating the potential for existing drugs to treat COVID-19. The result of this massive uncoordinated effort is frequent needless replication of effort and often poorly designed trials with little prospect for meeting the urgent clinical need. Recently, drugs designed specifically for treatment of COVID-19 called neutralizing monoclonal antibodies have become available and many more are on the way. The NIH has brought together the public and private sector in the “Accelerating COVID-19 Therapeutic Interventions and Vaccines” initiative. Part of this initiative is to test neutralizing monoclonal antibodies and potentially other treatments in hospitalized patients. In this talk we give a survey of our work designing and implementing a trial designed to rapidly test a large number of potential therapeutics as part of this NIH initiative.

Presented By

Cavan S. Reilly, PhD
Professor, Division of Biostatistics
Associate Director, Coordinating Centers for Biometric Research (CCBR)

Cavan Reilly focuses on design, implementation, and analysis of clinical research on infectious diseases, with an emphasis on HIV/AIDS and Ebola virus disease (EVD). Reilly also has interests in other chronic diseases such as chronic obstructive pulmonary disease (COPD). He is currently involved with multiple clinical trials and a cohort study of EVD survivors. View full bio

Description

In March 2020, forecasted critical PPE shortages at MHealth Fairview motivated the formation of an interdisciplinary team of researchers charged with designing and developing alternative PPE. The MNmask ‘Style 3’ team, composed of three women in STEM, met for the first time at the end of March. Six weeks later, the Style 3 mask design was licensed through the Office of Technology and Commercialization. In this talk I will describe this rapid response research process, product, and next steps.

Susan Arnold, PhD
Assistant Professor, Division of Environmental Health Sciences

Presented By

Susan Arnold specializes in developing, evaluating and applying mathematical exposure models to estimate exposures in novel occupational environments. She brings her 20-plus years of experience working in private industry as a certified industrial hygienist to her research. Arnold also serves as the director of the University of Minnesota Exposure Science and Sustainability Institute. The institute provides excellence in exposure science and sustainability research and training, responding to industry identified needs. Its activities include both services and products that help address specific research questions and provide specific deliverables to pre-defined customers. View full bio

Description

Hadija Steen Mills will present how her Community Informed COVID-19 Testing project was designed with the intent of serving communities disproportionately affected by COVID-19. Mills will discuss how the sites strive to be trauma-informed and embrace a harm reduction approach in addition to actively acknowledging and working against the harms enacted by traditional medical systems.

Presented By

Hadija Steen Mills (Pronouns: they|she)
Maternal and Child Health MPH program, Division of Epidemiology & Community Health

Hadija Steen Mills is a Queer, Mixed, Black parent of twins. Their work is rooted in Black feminist, transformative justice, and intersectional frameworks couched in a healthcare reparation ideology. They are a community organizer, sexuality educator, and first year student in the Maternal Child Health program.

Description

JP Leider will discuss ethical decision making and how the state, hospitals, and healthcare workers may need to make decisions about the allocation of scarce resources if the need arises.

Presented By

JP Leider, PhD
Senior Lecturer, Division of Health Policy & Management

JP Leider works with students in the Public Health Administration & Policy (PHAP) and Executive PHAP programs and teaches health policy, as well as budgeting and financial management. Leider is also director of evaluation for the Region V Public Health Training Center, associate faculty at the Johns Hopkins Bloomberg School of Public Health, and an independent consultant in the public health and health policy space with active projects and collaborations with foundations, national public health organizations, public health researchers and academics, and public health practitioners. His current projects focus on public health systems, the public health workforce, and public health finance. View full bio